KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Change in Cash (2016 - 2025)

Chemed (CHE) has 17 years of Change in Cash data on record, last reported at -$55.2 million in Q4 2025.

  • For Q4 2025, Change in Cash rose 8.09% year-over-year to -$55.2 million; the TTM value through Dec 2025 reached -$103.8 million, down 21.29%, while the annual FY2025 figure was -$103.8 million, 21.29% down from the prior year.
  • Change in Cash reached -$55.2 million in Q4 2025 per CHE's latest filing, up from -$120.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $101.9 million in Q2 2023 and bottomed at -$120.2 million in Q3 2025.
  • Average Change in Cash over 5 years is -$4.4 million, with a median of -$3.2 million recorded in 2022.
  • Peak YoY movement for Change in Cash: tumbled 1276.51% in 2021, then surged 1497.9% in 2022.
  • A 5-year view of Change in Cash shows it stood at $4.2 million in 2021, then soared by 1497.9% to $66.3 million in 2022, then surged by 36.87% to $90.8 million in 2023, then tumbled by 166.18% to -$60.1 million in 2024, then increased by 8.09% to -$55.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$55.2 million in Q4 2025, -$120.2 million in Q3 2025, and $76.0 million in Q2 2025.